Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy.
Cellerix is leading the development of a new generation of treatments using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials Phase I and II have been very promising.
Meet us at...
-
5th Annual Stem Cell Summit - New York, USA - February 16, 2010
-
EudraVigilance, Electronic Reporting of ICSRs in the EEA - London, UK - 17-19 February, 2010
- see more events.